Loading…
Do we need more anti-hypertensive drugs: lessons from the new biology
An increasing proportion of the adult population receives antihypertensive medication, resulting in a substantial decline in strokes and perhaps myocardial infarction. Shortcomings in current treatments, the importance of heterogeneity and the promise of molecular genetics are discussed.
Saved in:
| Published in: | The Lancet (British edition) 1995-06, Vol.345 (8964), p.1555-1557 |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c359t-b259819f489874221c2bd6d964e4d90a727e85f9343c345e22d201be60d49c173 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c359t-b259819f489874221c2bd6d964e4d90a727e85f9343c345e22d201be60d49c173 |
| container_end_page | 1557 |
| container_issue | 8964 |
| container_start_page | 1555 |
| container_title | The Lancet (British edition) |
| container_volume | 345 |
| creator | Bianchi, G. Swales, J.D. |
| description | An increasing proportion of the adult population receives antihypertensive medication, resulting in a substantial decline in strokes and perhaps myocardial infarction. Shortcomings in current treatments, the importance of heterogeneity and the promise of molecular genetics are discussed. |
| doi_str_mv | 10.1016/S0140-6736(95)91094-8 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77348624</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0140673695910948</els_id><sourcerecordid>2209962842</sourcerecordid><originalsourceid>FETCH-LOGICAL-c359t-b259819f489874221c2bd6d964e4d90a727e85f9343c345e22d201be60d49c173</originalsourceid><addsrcrecordid>eNqFkU9r1UAUxQdR6mv1IxSCStFFdGZy55-bUmqtQsGFCu6GZOamnZJkXmeSlvftTfoebyFIV3dxfudwOYeQY0Y_Msrkp5-UAS2lquR7Iz4YRg2U-hlZMVBQClB_npPVHnlJDnO-pZSCpOKAHChlGACsyMWXWDxgMSD6oo8Ji3oYQ3mzWWMaccjhHgufpuv8uegw5zjkok2xL8abxfNQNCF28Xrzirxo6y7j6909Ir-_Xvw6_1Ze_bj8fn52VbpKmLFsuDCamRa00Qo4Z443XnojAcEbWiuuUIvWVFC5CgRy7jllDUrqwTimqiNyss1dp3g3YR5tH7LDrqsHjFO2SlWgJYcZfPsPeBunNMy_Wc6pMZJr4DP15n8UM9oIqqSeIbGFXIo5J2ztOoW-ThvLqF2WsI9L2KVma4R9XMIuvuNd-NT06PeuXfWz_m6n19nVXZvqwYW8xyohBIgl5nSL4dzrfcBksws4OPQhoRutj-GJR_4C-DyhxA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>198950768</pqid></control><display><type>article</type><title>Do we need more anti-hypertensive drugs: lessons from the new biology</title><source>Business Source Ultimate</source><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Bianchi, G. ; Swales, J.D.</creator><creatorcontrib>Bianchi, G. ; Swales, J.D.</creatorcontrib><description>An increasing proportion of the adult population receives antihypertensive medication, resulting in a substantial decline in strokes and perhaps myocardial infarction. Shortcomings in current treatments, the importance of heterogeneity and the promise of molecular genetics are discussed.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(95)91094-8</identifier><identifier>PMID: 7791444</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Angiotensin II - genetics ; Animals ; Antihypertensive agents ; Antihypertensive Agents - therapeutic use ; Antihypertensives ; Biological and medical sciences ; Blood pressure ; Cardiovascular disease ; Cardiovascular system ; Drug therapy ; Drugs ; Fatty acids ; Genetic Markers ; Genetics ; Glucose ; Heart attacks ; Heterogeneity ; Humans ; Hypertension ; Hypertension - drug therapy ; Hypertension - genetics ; Insulin resistance ; Ischemia ; Medical research ; Medical sciences ; Meta-Analysis as Topic ; Metabolism ; Myocardial infarction ; Older people ; Peptidyl-Dipeptidase A - genetics ; Pharmaceutical industry ; Pharmacology ; Pharmacology. Drug treatments ; Polymorphism, Genetic ; Potassium ; Rats ; Treatment Outcome</subject><ispartof>The Lancet (British edition), 1995-06, Vol.345 (8964), p.1555-1557</ispartof><rights>1995</rights><rights>1995 INIST-CNRS</rights><rights>Copyright Lancet Ltd. Jun 17, 1995</rights><rights>Copyright Elsevier Limited Jun 17, 1995</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c359t-b259819f489874221c2bd6d964e4d90a727e85f9343c345e22d201be60d49c173</citedby><cites>FETCH-LOGICAL-c359t-b259819f489874221c2bd6d964e4d90a727e85f9343c345e22d201be60d49c173</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3555458$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7791444$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bianchi, G.</creatorcontrib><creatorcontrib>Swales, J.D.</creatorcontrib><title>Do we need more anti-hypertensive drugs: lessons from the new biology</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>An increasing proportion of the adult population receives antihypertensive medication, resulting in a substantial decline in strokes and perhaps myocardial infarction. Shortcomings in current treatments, the importance of heterogeneity and the promise of molecular genetics are discussed.</description><subject>Angiotensin II - genetics</subject><subject>Animals</subject><subject>Antihypertensive agents</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Antihypertensives</subject><subject>Biological and medical sciences</subject><subject>Blood pressure</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular system</subject><subject>Drug therapy</subject><subject>Drugs</subject><subject>Fatty acids</subject><subject>Genetic Markers</subject><subject>Genetics</subject><subject>Glucose</subject><subject>Heart attacks</subject><subject>Heterogeneity</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - genetics</subject><subject>Insulin resistance</subject><subject>Ischemia</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Meta-Analysis as Topic</subject><subject>Metabolism</subject><subject>Myocardial infarction</subject><subject>Older people</subject><subject>Peptidyl-Dipeptidase A - genetics</subject><subject>Pharmaceutical industry</subject><subject>Pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Polymorphism, Genetic</subject><subject>Potassium</subject><subject>Rats</subject><subject>Treatment Outcome</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><recordid>eNqFkU9r1UAUxQdR6mv1IxSCStFFdGZy55-bUmqtQsGFCu6GZOamnZJkXmeSlvftTfoebyFIV3dxfudwOYeQY0Y_Msrkp5-UAS2lquR7Iz4YRg2U-hlZMVBQClB_npPVHnlJDnO-pZSCpOKAHChlGACsyMWXWDxgMSD6oo8Ji3oYQ3mzWWMaccjhHgufpuv8uegw5zjkok2xL8abxfNQNCF28Xrzirxo6y7j6909Ir-_Xvw6_1Ze_bj8fn52VbpKmLFsuDCamRa00Qo4Z443XnojAcEbWiuuUIvWVFC5CgRy7jllDUrqwTimqiNyss1dp3g3YR5tH7LDrqsHjFO2SlWgJYcZfPsPeBunNMy_Wc6pMZJr4DP15n8UM9oIqqSeIbGFXIo5J2ztOoW-ThvLqF2WsI9L2KVma4R9XMIuvuNd-NT06PeuXfWz_m6n19nVXZvqwYW8xyohBIgl5nSL4dzrfcBksws4OPQhoRutj-GJR_4C-DyhxA</recordid><startdate>19950617</startdate><enddate>19950617</enddate><creator>Bianchi, G.</creator><creator>Swales, J.D.</creator><general>Elsevier Ltd</general><general>Lancet</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>19950617</creationdate><title>Do we need more anti-hypertensive drugs: lessons from the new biology</title><author>Bianchi, G. ; Swales, J.D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c359t-b259819f489874221c2bd6d964e4d90a727e85f9343c345e22d201be60d49c173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Angiotensin II - genetics</topic><topic>Animals</topic><topic>Antihypertensive agents</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Antihypertensives</topic><topic>Biological and medical sciences</topic><topic>Blood pressure</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular system</topic><topic>Drug therapy</topic><topic>Drugs</topic><topic>Fatty acids</topic><topic>Genetic Markers</topic><topic>Genetics</topic><topic>Glucose</topic><topic>Heart attacks</topic><topic>Heterogeneity</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - genetics</topic><topic>Insulin resistance</topic><topic>Ischemia</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Meta-Analysis as Topic</topic><topic>Metabolism</topic><topic>Myocardial infarction</topic><topic>Older people</topic><topic>Peptidyl-Dipeptidase A - genetics</topic><topic>Pharmaceutical industry</topic><topic>Pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Polymorphism, Genetic</topic><topic>Potassium</topic><topic>Rats</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bianchi, G.</creatorcontrib><creatorcontrib>Swales, J.D.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News & ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>ProQuest research library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bianchi, G.</au><au>Swales, J.D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Do we need more anti-hypertensive drugs: lessons from the new biology</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>1995-06-17</date><risdate>1995</risdate><volume>345</volume><issue>8964</issue><spage>1555</spage><epage>1557</epage><pages>1555-1557</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><abstract>An increasing proportion of the adult population receives antihypertensive medication, resulting in a substantial decline in strokes and perhaps myocardial infarction. Shortcomings in current treatments, the importance of heterogeneity and the promise of molecular genetics are discussed.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><pmid>7791444</pmid><doi>10.1016/S0140-6736(95)91094-8</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0140-6736 |
| ispartof | The Lancet (British edition), 1995-06, Vol.345 (8964), p.1555-1557 |
| issn | 0140-6736 1474-547X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_77348624 |
| source | Business Source Ultimate; ScienceDirect Freedom Collection 2022-2024 |
| subjects | Angiotensin II - genetics Animals Antihypertensive agents Antihypertensive Agents - therapeutic use Antihypertensives Biological and medical sciences Blood pressure Cardiovascular disease Cardiovascular system Drug therapy Drugs Fatty acids Genetic Markers Genetics Glucose Heart attacks Heterogeneity Humans Hypertension Hypertension - drug therapy Hypertension - genetics Insulin resistance Ischemia Medical research Medical sciences Meta-Analysis as Topic Metabolism Myocardial infarction Older people Peptidyl-Dipeptidase A - genetics Pharmaceutical industry Pharmacology Pharmacology. Drug treatments Polymorphism, Genetic Potassium Rats Treatment Outcome |
| title | Do we need more anti-hypertensive drugs: lessons from the new biology |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T20%3A33%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Do%20we%20need%20more%20anti-hypertensive%20drugs:%20lessons%20from%20the%20new%20biology&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Bianchi,%20G.&rft.date=1995-06-17&rft.volume=345&rft.issue=8964&rft.spage=1555&rft.epage=1557&rft.pages=1555-1557&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/S0140-6736(95)91094-8&rft_dat=%3Cproquest_cross%3E2209962842%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c359t-b259819f489874221c2bd6d964e4d90a727e85f9343c345e22d201be60d49c173%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=198950768&rft_id=info:pmid/7791444&rfr_iscdi=true |